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The fact that IgA comprises the body’s major isotype of
antibody on a biosynthetic basis is not widely appreciated
because IgG, not IgA, is the predominant isotype in serum.
Nevertheless, the bulk of the body’s Ig-producing cells re-
side in the various mucosal and exocrine sites, especially
along the intestinal tract, and most of them make IgA anti-
bodies against environmental antigens, including the local
microbial flora. These antibodies can then function in mul-
tiple ways as a first line of immune defense at boundaries
with the external environment (1).
It has long been recognized that a major source of the
precursors of the IgA plasma cells in the intestine is the or-
ganized lymphoid tissue of the Peyer’s patches (2). Here B
cells in the germinal centers are thought to switch from
IgM to IgA under the influence of T cells and cytokines, in
particular TGF-
 
 
 
 (3, 4). They then migrate from the
Peyer’s patches to the draining mesenteric lymph nodes,
where they continue to divide and differentiate. Finally
they exit the lymph nodes and pass via the thoracic duct
lymph into the blood, which carries them to the lamina
propria of the gut. Here they complete their differentiation
into the mature IgA-secreting plasma cells so characteristic
of this location (5, 6). During this process such Th2 cy-
tokines as IL-5, IL-6, and IL-10 are thought to be impor-
tant in inducing the switched B cells to make IgA for secre-
tion (3, 4). With regard to this IgA cell cycle, two points
are worth emphasizing. One, the precursors of the plasma
cells become committed to producing IgA well before they
reach the intestinal lamina propria, and two, trafficking to
lamina propria is independent of specific antigen even
though the presence of antigen in the lamina propria can
enhance the proliferation of the newly arrived B cells.
From a mechanistic viewpoint, what accounts for the
attraction of circulating IgA B cells to the mucosa of the
gut? The paradigm has been that the regional specificity of
lymphocyte trafficking is governed by the net effect of sets
of interacting local vascular endothelial receptors and their
respective counterreceptors on circulating lymphocytes (7).
These interactions are thought to account for the series of
steps that begins with transient binding of the lymphocytes
to endothelium and ends with their diapedesis across the
vascular wall. For trafficking to the gut, the MAdCAM-1
addressin on local venules and the 
 
 
 
4
 
 
 
7 integrin on the
lymphocyte are thought to be the key receptor–counter-
receptor pair. In addition to interactions between moieties
on lymphocytes and vascular endothelial cells, it was pro-
posed some years ago that a factor derived from mucosal
and/or exocrine epithelium might selectively attract the
circulating precursors of mucosal IgA plasma cells, and evi-
dence for the existence of such a chemotactic factor with
specificity for B cells committed to IgA was presented (8).
In marked contrast, however, to the wealth of molecular
information that has been published on lymphocyte and
endothelial receptors and their interactions, essentially no
progress was forthcoming in identifying a chemotactic fac-
tor for IgA-committed B cells or its receptor on homing
lymphocytes. This situation has just changed.
In this issue, Bowman et al. (9) provide compelling
evidence for such an IgA B cell chemotactic factor,
namely the chemokine thymus-expressed chemokine (TECK)
(CCL25). The research reported builds on work published
last year in which TECK was shown to be produced in pe-
ripheral tissues mainly in the epithelium of the small intes-
tine (10). Bowman et al. (9) have gone on to demonstrate
convincingly that TECK can attract IgA-committed B cells
from spleen, Peyer’s patches, and mesenteric lymph nodes
in a highly selective manner. Moreover, splenic IgA- but
not IgG-producing B cells also express high levels of
mRNA for the TECK receptor, CCR9. Based on these
data the authors propose that TECK and its receptor are
key participants in the mechanism of selective recruitment
of circulating IgA B cells to the gut lamina propria.
In earlier work, Bowman et al. (11) also showed that,
although very early in B cell development in the bone
marrow prepro-B cells were highly responsive and pro-B
cells were somewhat responsive to TECK, by the imma-
ture, IgM
 
 
 
 B cell stage they had lost their responsiveness
to TECK. The implication is that reacquisition of TECK
responsiveness by IgA-committed B cells is somehow as-
sociated with this commitment. It could be, however, that
the timing of acquisition of TECK responsiveness and its
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association with commitment to IgA is B-1 versus B-2
cell-lineage dependent. In this regard, Fagarasan et al. (12)
have recently provided evidence that switching to IgA
production by a substantial population of B220
 
 
 
IgM
 
 
 
 B
cells actually takes place in the gut lamina propria rather
than in the Peyer’s patches. Their studies indicate that
stimulation of B220
 
 
 
IgM
 
 
 
 B cells isolated from lamina
propria with a combination of LPS, IL-5, and TGF-
 
 
 
 is
sufficient to induce the switch to IgA and that T cells and
CD40–CD40 ligand interaction are not required. More-
over, factors produced by lamina propria stromal cells
have markedly enhancing effects on IgA-switching in
lamina propria B cells induced by LPS, IL-5, and TGF-
 
 
 
and support plasma cell differentiation.
At the interface between the work of these two groups is
the timing of entry of B cells into the lamina propria. In
the work of Bowman et al. (9) responsiveness to TECK,
which presumably promotes entry into the lamina propria,
is seen only in IgA-committed B cells in organized lym-
phoid tissues, whereas from the work of Fagarasan et al.
(12), the lamina propria of mice that lack activation-
induced cytidine deaminase, whose IgM
 
 
 
 B cells are inca-
pable of switching to IgA, contains many IgM
 
 
 
 B cells and
plasma cells. Presumably, these IgM
 
 
 
 B cells can respond
to TECK.
The results in the two studies may, perhaps, be recon-
ciled by considering that those of Bowman et al. (9) focus
mainly on conventional B-2 cell populations derived from
the bone marrow in adult mice. These undergo antigenic
stimulation and switching to IgA in the germinal centers of
organized lymphoid tissues including Peyer’s patches. The
studies of Fagarasan et al. (12), on the other hand, focus on
lamina propria IgM
 
 
 
 B cells many of which could be B-1
cells previously reported to give rise to a high proportion of
IgA plasma cells in lamina propria (13). B-1 cells are IgM
 
hi
 
/
IgD
 
lo
 
, Mac-1
 
 
 
, B220
 
lo
 
, Fc
 
 
 
R-negative and are selected for
overutilization of V
 
H
 
 and V
 
L
 
 genes that are associated with
specificity for certain “self” as well as microbial antigens
(14). In fetal mice, B-1 cell precursors develop in the liver
and omentum (15, 16), and in adult mice they form a self-
renewing population in the peritoneal and pleural cavities
(14). By contrast, conventional B-2 cells are IgM
 
lo
 
/IgD
 
hi
 
,
Mac-1
 
 
 
, B220
 
int to hi
 
 and are continuously produced in
adult mice from stem cells in the bone marrow. An impor-
tant behavioral difference between B-1 and B-2 cells is that
the former do not enter lymphoid follicles in lymph nodes
or spleen. Reconciliation between the two sets of findings
under discussion (9, 12) would be partially achieved if it
could be demonstrated that IgM
 
 
 
 B-1 cells in the perito-
neal cavity and/or peripheral blood, unlike the IgM
 
 
 
 pre-
Figure 1. An updated scheme for the IgA cell cycle.
(1) Switching of B-2 IgM  cells to IgA occurs in the
germinal centers of Peyer’s patches in the small intes-
tine. (2) B-2 cells from the Peyer’s patch leave in
lymph and go to the draining mesenteric lymph node.
(3) Further proliferation and maturation take place in
the mesenteric lymph node. (4) IgA-committed plas-
mablasts derived from B-2 cells leave the mesenteric
lymph node in the efferent lymph and travel via the
thoracic duct to the blood, which transports them to
the small intestine. (5) At this site, TECK produced lo-
cally by epithelial cells attracts the IgA plasmablasts into
the lamina propria. (6) In contrast, B-1 cells sojourn in
the peritoneal cavity. (7) IgM  B-1 cells leave the peri-
toneal cavity and enter the bloodstream. It is not
known for certain how they do this. One possibility,
consistent with the behavior of particles injected into
the peritoneal cavity, is that they traverse the dia-
phragm in lymphatics and enter the mediastinal lymph
nodes via their afferent lymphatics. They then pass
through the marginal, cortical, and medullary sinuses
without entering the follicles and exit via the efferent
lymphatics which take them to the thoracic duct and
thence to the blood. There they join the IgA plasma-
blasts derived from B-2 cells. Like them, they exit from
the blood into lamina propria (at 5), presumably in re-
sponse to TECK, but unlike them, they are still IgM .
They switch to IgA in the lamina propria. 
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sumably B-2 cells in the spleen studied by Bowman et al.
(9), are responsive to TECK. Perhaps the set of stimuli that
keeps B-1 cells ticking over in the peritoneal cavity also
promotes or maintains upregulation of CCR9. Once
TECK-responsive IgM
 
 
 
 B-1 cells reach the blood, their at-
traction to lamina propria would inevitably expose them to
stromal influences, especially LPS and TGF-
 
 
 
, that pro-
mote switching to IgA. Further reconciliation would re-
quire demonstration that IgM
 
 
 
 and IgG
 
 
 
 B-2 cells in
Peyer’s patches are TECK unresponsive. If they are unre-
sponsive, then it may be that the same stimulus set that pro-
motes switching to IgA, namely CD40 ligand and TGF-
 
 
 
,
upregulates CCR9 while the stimulus sets consisting of
CD40 ligand and IL-4 or IFN-
 
 
 
, which promote switching
to IgG1 or IgG2a, respectively, do not. Fig. 1 presents a
scheme for the development of B-1 and B-2 IgA plasma
cells in the intestinal lamina propria.
It is likely that CCR9 expression is upregulated by other
stimulus-receptor sets besides those that promote switching
to IgA, not only because TECK is expressed on bone mar-
row prepro-B cells (11), but also because subsets of T cells
also evidence trafficking to the gut (17). Both CD4 and
CD8 gut-seeking T cells express the 
 
 
 
4
 
 
 
7 integrin and the
CCR9 chemokine receptor, and are attracted by TECK
(10). This consideration strengthens the conclusion that al-
though isotype-switching and differentiation toward secre-
tion of IgA by the B-2 cell precursors of gut plasma cells
develops spatially and temporally along with their ability to
traffic to the lamina propria, this is apparently not true of
the B-1 cell precursors. It may only be in the Peyer’s patch
that the two functions are controlled by the same stimuli.
What are some of the implications of the paper by Bow-
man et al. (9) and related papers for our understanding of
regional immunity, for future research, and for dealing
with disease? For one, the data strongly suggest that local
mechanisms for attracting lymphocytes to mucosal tissues
involve more than vascular endothelial receptors and spe-
cifically implicate chemokines. In this regard it will be im-
portant to demonstrate in intact animals that TECK and its
receptor are indeed critical for homing to the intestinal
lamina propria. Second, the data provide further evidence
that homing by lymphocytes can be highly localized, even
within the so-called “common mucosal immune system”
and even within the gastrointestinal tract. Thus, the inter-
action between the CCR9 receptor and the TECK
chemokine applies much more to the small than to the
large intestine, and does not appear to apply at all to other
mucosae, such as in the respiratory tract. Even within the
small intestine TECK appears to be expressed more in je-
junum and ileum than in duodenum (10). Therefore, fruit-
ful studies will undoubtedly be directed toward under-
standing the particular receptor-counterreceptor pairs that
promote homing to other mucosal sites, most importantly,
in the context of infectious disease, in the upper respiratory
tract. Through such knowledge it should be possible in the
case of selected diseases to develop specific inhibitors capa-
ble of reducing the traffic of the offending subset(s) of lym-
phocytes to the site where disease is manifest. The implica-
tions for inflammatory bowel disease and perhaps asthma,
for example, are evident. On the other hand, to enhance
the effectiveness of vaccines that are designed to induce
protective immunity against infections at particular mucosal
sites, it might be possible to take advantage of agents that
upregulate the receptors responsible for selective migration
of immunocytes to the site. Finally, if the differentiation
pathway described by Fagarasan et al. (12), in which IgM-
producing cells switch to IgA production in situ in the in-
testinal mucosa, is in fact a B-1 cell pathway of significance
in humans, by exploiting knowledge of the mechanisms
underlying recruitment of the IgM precursor cells, it should
be possible to develop vaccination regimens to enhance
production of local IgA antibodies able to counter infec-
tions caused by the kinds of bacteria to which B-1 cell re-
sponses are directed.
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